MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

Free Cash flow
-$111,581K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-130,091 -212,411
Stock-based compensation
22,702 46,602
Depreciation and amortization
1,012 1,884
Deferred revenue
-984
Noncash lease expense
2,360 -
Accounts payable and accrued expenses, compensation and related expenses
-11,160
Accretion of purchase discounts and amortization of premiums on investment securities, net
3,601 9,090
Loss on disposal of property and equipment
0 -42
Loss on equity method investment
0 0
Prepaid expenses and other assets
7,206 11,325
Accounts payable and accrued expenses, compensation and related expenses, and other liabilities
17,807 -
Noncash lease expense
-1,605
Deferred revenue
-1,128 -
Operating lease liabilities
-2,578 -1,786
Net cash used in operating activities
-110,718 -174,303
Purchases of investment securities
216,700 574,081
Proceeds from sales and maturities of investment securities
382,372 530,514
Purchases of property and equipment
863 4,441
Net cash provided by (used in) investing activities
164,809 -48,008
Proceeds from issuance of common stock, net of commissions
0 0
Offering costs related to issuance of common stock
-0
Proceeds from exercise of stock options and shares issued under employee stock purchase plan
3,084 11,492
Net cash provided by financing activities
3,084 11,492
Net change in cash, cash equivalents and restricted cash
57,175 -210,819
Cash and cash equivalents at beginning of period
265,845 -
Cash and cash equivalents at end of period
112,201 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals, Inc. (CRNX)